This target price adjustment aligns with investors shifting their focus towards the third quarter results of the SURPASS-CVOT ...

U.K. regulators issued guidance on Thursday, warning weight loss and diabetes medications may weaken the effectiveness of ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Anecdotes abound about “Ozempic babies”—when women wound up with unplanned pregnancies while taking both birth-control and ...

Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

Mounjaro (tirzepatide), a weight-loss injection, is now approved to treat moderate-to-severe obstructive sleep apnea in obese ...

To truly shift the landscape in obesity care, explains Jaime Almandoz, MD, MBA, UT Southwestern, care models and policies ...

Apple cider vinegar can cause side effects when taking it and certain medications. Learn which medications apple cider ...

A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...

Now, let's return to our question: Should you invest $1,000 in Lilly right now? The shares are trading for 34 times forward ...